PLK1 and cancer: Blocking PLK1 seems a promising cancer-therapeutic strategy via arresting cells in mitosis31; however, PLK1 inhibitors do not obtain satisfactory results in clinical trials, which is probably associated with complex regulatory mechanisms of PLK1 in various types of cancer20,32,33.